Canadian Sec - Delayed Quote CAD
Braxia Scientific Corp. (BRAX.CN)
0.0050
0.0000
(0.00%)
At close: August 2 at 2:14:34 PM EDT
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
2,209.1660
1,884.1710
1,487.1560
1,008.3720
Cost of Revenue
1,885.0580
1,712.4280
1,240.2840
862.7060
Gross Profit
324.1080
171.7430
246.8720
145.6660
Operating Expense
4,519.5300
7,602.6410
7,381.8430
10,671.5030
Operating Income
-4,195.4220
-7,430.8980
-7,134.9710
-10,525.8370
Net Non Operating Interest Income Expense
-58.8550
-17.8410
-4.9530
-3.2630
Other Income Expense
-5,531.7220
-5,838.8470
-5,039.4340
-78,299.0460
Pretax Income
-9,785.9990
-13,287.5860
-12,179.3580
-88,828.1460
Tax Provision
--
-145.8820
-45.2670
--
Net Income Common Stockholders
-9,640.1170
-13,141.7040
-12,134.0910
-88,828.1460
Diluted NI Available to Com Stockholders
-9,640.1170
-13,141.7040
-12,134.0910
-88,828.1460
Basic EPS
-0.05
-0.06
-0.07
-0.56
Diluted EPS
-0.05
-0.06
-0.07
-0.56
Basic Average Shares
259,912.6030
228,420.7090
175,243.6780
157,639.9360
Diluted Average Shares
259,912.6030
228,420.7090
175,243.6780
157,639.9360
Total Operating Income as Reported
-4,438.5580
-7,480.1350
-7,129.6640
-10,541.5480
Total Expenses
6,404.5880
9,315.0690
8,622.1270
11,534.2090
Net Income from Continuing & Discontinued Operation
-9,640.1170
-13,141.7040
-12,134.0910
-88,828.1460
Normalized Income
-4,140.0170
-7,349.7408
-7,117.1600
-10,529.1000
Interest Expense
58.8550
17.8410
4.9530
3.2630
Net Interest Income
-58.8550
-17.8410
-4.9530
-3.2630
EBIT
-9,727.1440
-13,269.7450
-12,174.4050
-88,824.8830
EBITDA
-9,361.6920
-12,703.8610
-12,151.2360
-88,805.0870
Reconciled Cost of Revenue
1,885.0580
1,712.4280
1,240.2840
862.7060
Reconciled Depreciation
365.4520
565.8840
23.1690
19.7960
Net Income from Continuing Operation Net Minority Interest
-9,640.1170
-13,141.7040
-12,134.0910
-88,828.1460
Total Unusual Items Excluding Goodwill
-5,500.1000
-5,856.2580
-5,035.6470
-78,299.0460
Total Unusual Items
-5,500.1000
-5,856.2580
-5,035.6470
-78,299.0460
Normalized EBITDA
-3,861.5920
-6,847.6030
-7,115.5890
-10,506.0410
Tax Rate for Calcs
--
0
0
--
Tax Effect of Unusual Items
--
-64.2948
-18.7160
--
3/31/2021 - 3/2/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COOL.CN Core One Labs Inc.
0.1450
0.00%
PHRM.CN PharmaTher Holdings Ltd.
0.1850
0.00%
BOLT Bolt Biotherapeutics, Inc.
0.3890
+4.57%
PHRRF PharmaTher Holdings Ltd.
0.1390
0.00%
MDMA.CN Pharmala Biotech Holdings Inc.
0.1400
0.00%
CYBN.NE Cybin Inc.
9.73
+1.88%
CTMX CytomX Therapeutics, Inc.
0.7658
+4.88%
ATAI Atai Life Sciences N.V.
1.5300
+0.66%
MNMD Mind Medicine (MindMed) Inc.
6.43
+5.24%